A strategy for an unlicensed medicine supplier
UL Medicines was a relative newcomer to the unlicensed market. Their market entry approach was not to charge the exorbitant prices their competitors charged for unlicensed medicines. However, this turned some customers away as they thought they were not an ethical pharma company they wanted to do business with. The substandard branding of the company did not help this.